MOUD: Medications Maintenance, and Myths

A MEDS Ed seminar

Key Session Takeaways

(click the link to view a clip):

• MOUD and mortality reduction: Part 1 - 5:20
• Barriers to MOUD: Part 1 – 6:57
• Buprenorphine basics: Part 1 – 9:49
• Myth #1 – One can’t achieve pain control while on buprenorphine. Fact – It is possible to achieve pain control with buprenorphine! Part 1 – 11:48
• Fentanyl in the drug supply: Part 1 – 13:05
• Overview of buprenorphine transition options: Part 1 – 13:52
• Standard dosing option: Part 1 – 16:40
• Low dosing option: Part 1 – 18:08
• High dosing option: Part 1 – 19:22
• Standard dose initiation: Part 1 – 20:07
• Low dose initiation: Part 1 – 21:18
• Example patient dosing table: Part 1 – 25:41
• High dose initiation: Part 1 – 26:34
• CA Bridge Buprenorphine Self-Start Guide: Part 1 – 27:24
• Low-to-high dose initiation: Part 1 – 28:17
• Adjunct medications for opioid withdrawal: Part 1 – 30:10
• Long term dosing: Part 1 – 32:50
• Myth #2 – The maximum dose of buprenorphine is 24mg. Fact – One can use up to 32mg of buprenorphine, when appropriate: Part 1 - 33:02
• Buprenorphine administration technique: Part 1 - 34:36
• Myth #3 - Patients who use multiple substances should not use buprenorphine. Fact- Patients who use multiple substances are often able to use buprenorphine– Part 1 37:45
• Benzodiazepines and buprenorphine: Part 1 – 39:15
• Co-occurring mental health disorders: Part 1 – 45:02
• Buprenorphine and stimulants: Part 1 – 50:37
• Buprenorphine and cannabis: Part 1 – 53:39
• General approach for those using multiple substances: Part 1 – 56:20

   

• Pros and cons of injectable ER buprenorphine: Part 2 – 0:10
• Injectable ER buprenorphine options: Part 2 – 2:52
• Sublocade pharmacokinetics: Part 2 – 3:43
• Sublocade serum levels: Part 2 – 5:48
• Sublocade starts: Part 2 – 7:30
• Sublocade updates: Part 2 – 9:52
• Sublocade missed doses: Part 2 – 13:42
• Brixadi pharmacokinetics: Part 2 – 14:56
• Brixadi serum levels: Part 2 – 17:17
• Brixadi starts/dose titration: Part 2 – 18:52
• Brixadi dosing: Part 2 – 20:26
• Serum levels of Brixadi – daily, weekly, monthly: Part 2 - 23:04
• Switching between products: Part 2 – 27:23
• Things to consider when choosing formulation: Part 2 – 29:24
• Injectable to taper off sublingual: Part 2 – 31:16
• Steps to obtaining in clinic: Part 2 – 32:57
• Naloxone: Part 2 – 36:23
• Audience question: Are there any medications for methamphetamine use disorder? Part 2 – 38:32
• Audience question: Contingency management overview: Part 2 – 42:22
• Audience question: Is it common to need to give multiple Narcan/naloxone doses in an overdose event?: Part 2 – 44:54
• Audience question: Use of bupropion in patients with severe congestive heart failure related to methamphetamine?: Part 2 – 44:47
• Audience question: If naloxone is expired, is it still safe to administer?: Part 2 – 49:28